首页> 美国卫生研究院文献>RMD Open >Original article: Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible

【2h】

Original article: Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible

机译：原始文章：不符合TNF抑制剂随机对照试验条件的银屑病关节炎患者的治疗反应和药物生存率与符合条件的患者相似

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectivesTo determine in a retrospective cohort whether patients with psoriatic arthritis (PsA) who would not have fulfilled the inclusion criteria for randomised controlled trials (RCTs) for the TNF inhibitor (TNFi) chosen for their treatment (excl) have similar benefits and drug survival as those patients who would have (incl).

机译：目的在一项回顾性队列研究中确定银屑病关节炎（PsA）的患者是否不符合为治疗（excl）选择的TNF抑制剂（TNFi）进行的随机对照试验（RCT）纳入标准，其益处和药物生存率是否与那些会（包括）的患者。

著录项

期刊名称 RMD Open
作者
Olafur Palsson; Thorvardur Jon Love; Anna Ingibjorg Gunnarsdottir; Petur Sigurdur Gunnarsson; Eydis Erla Runarsdottir; Niels Steen Krogh; Bjorn Gudbjornsson;
展开▼
作者单位

展开▼
年(卷),期 2019(5),2
年度 2019
页码 e000984
总页数 7
原文格式 PDF
正文语种
中图分类
关键词
psoriatic arthritis arthritis anti-tnf DMARDs (biologic) outcomes research;

机译：银屑病关节炎;关节炎;抗tnf;DMARDs（生物学的）;结果研究;

相似文献

外文文献
中文文献
专利

1. Original article: Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible [J] . Olafur Palsson, Thorvardur Jon Love, Anna Ingibjorg Gunnarsdottir, RMD Open . 2019,第2期

机译：原始文章：不符合TNF抑制剂随机对照试验条件的银屑病关节炎患者的治疗反应和药物生存率与符合条件的患者相似
2. Patients with psoriatic arthritis who are not eligible for randomized clinical trials for tumour necrosis factor inhibitors have similar treatment response and drug survival [J] . Palsson O., Johannsdottir G. A., Runarsdottir E., Scandinavian journal of rheumatology . 2018,第Suppla129期

机译：没有资格用于肿瘤坏死因子抑制剂随机临床试验的银屑病关节炎的患者具有类似的治疗反应和药物存活
3. Original article: Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond [J] . Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, RMD Open . 2019,第1期

机译：原始文章：托法替尼对活动性银屑病关节炎患者报告的结局的影响，并且在III期随机对照试验中对肿瘤坏死因子抑制剂的反应不足：OPAL Beyond
4. Development of TNF-alpha Inhibitor Drugs in Treatment of Rheumatoid Arthritis [C] . Dong Jin-rui, He Ming-hao, Han Mo, Biomedical Engineering and Biotechnology (iCBEB), 2012 International Conference on . 2012

机译：TNF-α抑制剂在类风湿关节炎治疗中的应用
5. Examining time to rearrest by drug treatment experience of drug court eligible offenders [D] . Rocha, Carlos M. 2011

机译：通过符合毒品法庭资格的罪犯的药物治疗经验来重新审查时间
6. Original article: Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III randomised controlled trial: OPAL Beyond [O] . Vibeke Strand, Kurt de Vlam, Jose A Covarrubias-Cobos, 2019

机译：原始文章：托法替尼对活动性银屑病关节炎患者报告的结局的影响并且在III期随机对照试验中对肿瘤坏死因子抑制剂的反应不足：OPAL Beyond
7. Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible [O] . Olafur Palsson, Thorvardur Jon Love, Anna Ingibjorg Gunnarsdottir, 2019

机译：没有资格用于TNF抑制剂随机对照试验的银屑病关节炎的患者具有与符合条件的人相似的治疗反应和药物存活

Original article: Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible

摘要

著录项

相似文献

相关主题

期刊订阅